FDA guidance, Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (February 3, 2026; docket FDA-2021-D-1158) · Effective (as of November 14, 2026)
Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
The guidance sets out FDA's recommendations on cybersecurity in device design and labeling and on the cybersecurity documentation to include in premarket submissions, and covers its recommendations under section 524B for cyber devices, including the software bill of materials. It treats cybersecurity as part of device safety and of the Quality Management System Regulation, and describes a secure product development framework as one way to satisfy that regulation. The February 3, 2026 version supersedes the June 27, 2025 version and aligns the text with the amended 21 CFR part 820, which took effect on February 2, 2026.